Latest Announcements

Alivus Life Sciences Limited has reported Q1 FY27 results, with revenue growth of 6.4% YoY, driven by strong momentum in the non-GPL business, and EBITDA margins of 36.6%. The company expects revenue growth of 10-12% in FY27 and sustaining EBITDA margins in the 30-32% range.

SBI Cards and Payment Services Limited has announced its Q1 FY27 earnings call transcript, highlighting India's strong macroeconomic fundamentals and the growth of the digital payment ecosystem. The company's strategy remains focused on strengthening its market position through disciplined execution, customer-centric innovation, and sustained investments in digital capabilities.

Alivus Life Sciences Limited has announced its financial results for the quarter ended June 30, 2026, with revenue from operations at Rs. 6,404 Mn, a growth of 6.4% YoY, driven by robust performance in the non-GPL business. EBITDA for Q1FY27 stood at Rs. 2,341 Mn, a growth of 29.1% YoY with margins at 36.6%, and PAT for Q1FY27 stood at Rs. 1,601 Mn, a growth of 31.8% YoY with margins at 25.0%. The company generated a strong free cash flow of Rs. 901 Mn, leading to Cash and Cash Equivalents (including short-term investments) of Rs. 8,802 Mn as of June 30, 2026.

Data Patterns (India) Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a profit before tax of ₹29.48 crores and a profit for the period/year of ₹22.06 crores.

Aeroflex Industries Limited reported its Q1 FY27 earnings, with a 72.4% year-on-year increase in consolidated revenue to INR145.97 crores. The company's flexible hose business grew 41% YoY, and revenue from SFN Skid Assemblies reached INR32.4 crores, contributing 23% to the total revenue. The company expanded its capacity for skid assemblies and plans to further increase it to 15,000 units per annum. Aeroflex also invested in automation, advanced welding solutions, and precision manufacturing to strengthen product quality and reliability.

Alivus Life Sciences Ltd reported Q1FY27 results with revenue growth of 6.4% YoY, EBITDA growth of 29.1% YoY, and PAT growth of 31.8% YoY. The company achieved its highest-ever PAT margin of 25.0% and EBITDA margin of 36.6%. The company also announced plans for capacity expansion and pipeline development.

Sugs Lloyd Ltd reported Q1 FY27 revenue of ₹78.40 crore, a 32% YoY increase, and PAT of ₹7.50 crore, a 30% YoY increase. The company's order book stands at ₹807 crore, approximately 2.7 times FY26 revenue.

Sapphire Foods India Ltd has informed the Exchange about the transcript of earnings call held on July 24, 2026, in relation to the financial results of the Company for the quarter ended June 30, 2026. The transcript is available on the Company's website under FY 2026-27 Quarter 1 section.

Sapphire Foods India Limited has announced its Q1 FY27 earnings, with revenue growth of 15% and adjusted EBITDA growth of 32% year-on-year, driven by positive same-store sales growth across all three brand verticals.

SBI Life Insurance Company Limited has announced its Q1 FY 2027 earnings, with a 14% increase in Individual Rated Premium and a 20% growth in Gross Written Premium. The company's profit after tax for the quarter stood at INR7.2 billion, registering a 22% growth over the corresponding quarter of previous year.

Tata Steel Ltd's Board of Directors approved the Audited Standalone and Unaudited Consolidated Financial Results for the quarter ended June 30, 2026, and also approved the core project of steelmaking capacity expansion by 4.8 MTPA in NINL at an estimated capex of ₹33,873 crore.

NIIT Learning Systems Limited has informed the Exchange about Earnings Call Transcript for Q1 FY27. The company's revenue grew 25% year-on-year, with 11% growth excluding the contribution from two acquisitions made in FY26. The management consulting and professional services sector degrew 16% year-on-year.

Dhampur Sugar Mills Ltd has redeemed its commercial paper, fulfilling its payment obligations as per SEBI's Master Circular.

SBI Life Insurance Company Ltd reported a 14% increase in Individual Rated Premium and a 20% growth in Gross Written Premium for the quarter ended June 30, 2026, with a profit after tax of INR7.2 billion, a 22% growth over the corresponding quarter of previous year.

Munjal Showa Ltd submitted its annual report for FY 2025-26 and announced a dividend of ` 4.50 per equity share, maintaining the same level as the previous year. The company delivered steady revenue growth of 5.2% to ` 1,315.42 crore, compared with ` 1,250.45 crore in the previous year.

Gravita India Limited has informed the Exchange about the transcript of the earnings conference call for the quarter ended June 30, 2026. The company's leadership team discussed key business developments, strategic initiatives, operational highlights, and financial performance for the quarter. Gravita achieved a significant global milestone with the London Metal Exchange Brand Listing for lead metal produced at its division in Mundra, Gujarat. The company reported a 4% growth in volumes, 42% in revenue, 29% in EBITDA, and 14% in PAT on a year-on-year basis.

Gravita India Ltd has announced its Q1 FY27 earnings conference call transcript, highlighting a 4% growth in volumes, 42% in revenue, 29% in EBITDA, and 14% in PAT on a year-on-year basis. The company has also achieved a significant global milestone with the London Metal Exchange Brand Listing for lead metal produced at its Mundra division.

Global Health Ltd (MEDANTA) has announced its Q1 FY2027 results, with revenue growth of 26% y-o-y, primarily led by increase in patient volumes and realization. EBITDA (ex-Noida) grew 23.9% y-o-y to INR 3,201 with improved margins of 25.8% in Q1 FY27. Noida hospital generated Total Income of INR 855 million and EBITDA loss of INR 49 million in Q1 FY27, compared to total income of INR 525 million and EBITDA loss of INR 236 million reported in Q4 FY26.

Global Health Limited has informed the Exchange about Investor Presentation for the first quarter ended June 30, 2026 Results. The presentation highlights a revenue growth of 26% y-o-y, primarily led by increase in patient volumes and realization. EBITDA (ex-Noida) grew 23.9% y-o-y to INR 3,201 with improved margins of 25.8% in Q1 FY27. Profit After Tax was INR 1,573 million, compared to INR 1,590 million in Q1FY26.

Global Health Limited, one of the largest private multi-specialty tertiary care providers in India, announced its unaudited consolidated financial results for the quarter ending June 30, 2026. The company reported a 26.2% year-over-year growth in total income to INR 13,262 million and a 23.9% year-over-year growth in EBITDA (ex-Noida) to INR 3,201 million with improved margins of 25.8% in Q1 FY27.